Profile | GDS4284 / 206839_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 329.475 | 58 |
GSM687648 | Patient 402 control | 265.94 | 54 |
GSM687653 | Patient 403 control | 259.618 | 54 |
GSM687658 | Patient 404 control | 269.818 | 54 |
GSM687663 | Patient 411 control | 227.348 | 50 |
GSM687668 | Patient 422 control | 200.758 | 49 |
GSM687673 | Patient 424 control | 283.515 | 54 |
GSM687678 | Patient 425 control | 252.05 | 51 |
GSM687683 | Patient 427 control | 349.307 | 56 |
GSM687688 | Patient 428 control | 307.233 | 56 |
GSM687695 | Patient 441 control | 669.415 | 68 |
GSM687699 | Patient 443 control | 439.839 | 60 |
GSM687704 | Patient 444 control | 138.664 | 41 |
GSM687707 | Patient 448 control | 310.437 | 54 |
GSM687712 | Patient 449 control | 239.672 | 51 |
GSM687719 | Patient 450 control | 329.862 | 55 |
GSM687724 | Patient 451 control | 249.87 | 51 |
GSM687728 | Patient 452 control | 203.531 | 47 |
GSM687646 | Patient 401 treated 24h | 302.922 | 55 |
GSM687649 | Patient 402 treated 24h | 295.367 | 56 |
GSM687665 | Patient 411 treated 24h | 364.575 | 58 |
GSM687651 | Patient 402 treated 4 weeks | 312.909 | 55 |
GSM687667 | Patient 411 treated 4 weeks | 259.364 | 52 |
GSM687670 | Patient 422 treated 24h | 242.322 | 51 |
GSM687671 | Patient 422 treated 4 weeks | 174.436 | 46 |
GSM687654 | Patient 403 treated 24h | 303.89 | 57 |
GSM687675 | Patient 424 treated 24h | 323.551 | 55 |
GSM687685 | Patient 427 treated 24h | 260.462 | 53 |
GSM687656 | Patient 403 treated 4 weeks | 284.053 | 56 |
GSM687677 | Patient 424 treated 4 weeks | 171.344 | 45 |
GSM687687 | Patient 427 treated 4 weeks | 197.748 | 49 |
GSM687692 | Patient 428 treated 4h | 254.442 | 53 |
GSM687716 | Patient 449 treated 4h | 131.624 | 40 |
GSM687722 | Patient 450 treated 4h | 492.326 | 62 |
GSM687680 | Patient 425 treated 24h | 323.131 | 57 |
GSM687690 | Patient 428 treated 24h | 236.557 | 53 |
GSM687700 | Patient 443 treated 24h | 585.345 | 64 |
GSM687705 | Patient 444 treated 24h | 207.811 | 51 |
GSM687714 | Patient 449 treated 24h | 320.475 | 58 |
GSM687721 | Patient 450 treated 24h | 415.925 | 59 |
GSM687682 | Patient 425 treated 4 weeks | 222.904 | 51 |
GSM687694 | Patient 428 treated 4 weeks | 252.014 | 54 |
GSM687702 | Patient 443 treated 4 weeks | 275.268 | 52 |
GSM687718 | Patient 449 treated 4 weeks | 255.876 | 53 |
GSM687723 | Patient 450 treated 4 weeks | 248.392 | 51 |
GSM687661 | Patient 404 treated 4h | 226.658 | 50 |
GSM687710 | Patient 448 treated 4h | 274.884 | 55 |
GSM687726 | Patient 451 treated 4h | 321.628 | 55 |
GSM687730 | Patient 452 treated 4h | 561.451 | 59 |
GSM687660 | Patient 404 treated 24h | 372.592 | 58 |
GSM687697 | Patient 441 treated 24h | 454.581 | 60 |
GSM687709 | Patient 448 treated 24h | 145.185 | 40 |
GSM687725 | Patient 451 treated 24h | 431.92 | 60 |
GSM687729 | Patient 452 treated 24h | 530.019 | 65 |
GSM687727 | Patient 451 treated 4 weeks | 252.788 | 50 |
GSM687731 | Patient 452 treated 4 weeks | 258.307 | 51 |